Viela Bio goes public, nets $160.5mm
Viela Bio Inc. (developing treatments for autoimmune and severe inflammatory diseases) netted $160.5mm in its initial public offering of 9.1mm common shares (including the overallotment) at $19. The company originally filed to sell 7.5mm shares at a range of $19-21.
- Large Molecule
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com